Юго-Западный мозговой банк запускает программу донорства головного мозга и спинного мозга PFS

SOMERSET, N.J., July 15, 2015 – The Southwest Brain Bank (SWBB) in the Department of Psychiatry at the University of Texas Health Science Center in San Antonio has received its first donation of the brain and spinal cord of a post-finasteride syndrome (PFS) patient and formed a program to collect and study post-mortem human brain […]

Национальный институт здравоохранения США добавляет PFS в Информационный центр по генетическим и редким заболеваниям

May 19, 2015 Dear Public Health Official: The U.S. National Institutes of Health recently added post-finasteride syndrome (PFS) to its Genetic and Rare Diseases Information Center, noting that: “Studies are underway to understand the safety profile of 5-alpha reductase inhibitor drugs with respect to adverse events…and their permanency.” This federal listing of PFS comes in […]

Клиническое исследование постфинастеридного синдрома запущено в Миланском университете и Миланском университете

SOMERSET, N.J., Dec. 9, 2014 – The Post-Finasteride Syndrome Foundation today announced the funding of a third clinical study on post-finasteride syndrome (PFS), this one a collaboration between the University of Milano-Bicocca and the University of Milano, both in Italy. Titled “Rare, but Serious and Persistent, Side Effects of 5α Reductase Inhibitors (5ARI): Why Do […]

Число стран, подключившихся к веб-сайту Фонда PFS, увеличилось еще на 26% в первой половине 2014 года

SOMERSET, N.J., July 8, 2014 – The number of nations that logged onto the Post-Finasteride Syndrome Foundation website rose 26 percent during the first half of 2014, according to Google Analytics. In all, users in 147 countries—or 75 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed […]

Даниэль М. Стюарт: 1976-2014

April 25, 2014 Dear Friends: The Post-Finasteride Syndrome Foundation is saddened to announce the passing of Daniel M. Stewart. The 37-year-old native of Troy, Michigan, and Centertown, Kentucky, died Saturday, April 12, 2014 at his home in Denton, Texas. Daniel, who suffered from post-finasteride syndrome, had recently taken part in a clinical-research study on the […]

Напоминание: сообщить о симптомах PFS в FDA MedWatch

SOMERSET, N.J., Oct. 29, 2013 – The Post-Finasteride Syndrome Foundation is reminding PFS patients to report all persistent side effects to the FDA MedWatch program. MedWatch is the U.S. Food and Drug Administration’s system for detecting safety-hazard signals for pharmaceutical products and medical devices. If a signal is detected, the FDA can issue safety alerts, […]

Врачи набирают пациентов с ПФС для научных исследований

SOMERSET, N.J., June 16, 2014 – Post-finasteride syndrome research initiatives at two major U.S. medical institutions, Brigham and Women’s Hospital (a Harvard Medical School Teaching Affiliate) in Boston, Mass., and Baylor College of Medicine in Houston, Texas, are currently recruiting patients for their respective studies on the condition. If you are interested in participating, or […]

Ежегодное обращение Фонда PFS за 2013 год

Aug. 4, 2013 Dear Friends: When we incorporated the Post-Finasteride Syndrome Foundation in July 2012, our mission was clear: To fund research on the characterization, underlying biologic mechanisms and treatments of PFS while raising public awareness of this often life-altering condition afflicting thousands of men the world over. Now, on the occasion of our one-year […]

Запрос пациента PFS: случаи самоубийства

  August 7, 2013   Dear Friends: The PFS Foundation is seeking information about patients who have taken finasteride or dutasteride, and who have attempted suicide or who have completed suicide. This is an area of active research interest and researchers are seeking to obtain medical records and other relevant material for such patients. To […]